| Literature DB >> 31543366 |
Markus Riessland1, Benjamin Kolisnyk2, Tae Wan Kim3, Jia Cheng2, Jason Ni2, Jordan A Pearson2, Emily J Park2, Kevin Dam2, Devrim Acehan4, Lavoisier S Ramos-Espiritu5, Wei Wang2, Jack Zhang2, Jae-Won Shim6, Gabriele Ciceri3, Lars Brichta2, Lorenz Studer7, Paul Greengard2.
Abstract
Cellular senescence is a mechanism used by mitotic cells to prevent uncontrolled cell division. As senescent cells persist in tissues, they cause local inflammation and are harmful to surrounding cells, contributing to aging. Generally, neurodegenerative diseases, such as Parkinson's, are disorders of aging. The contribution of cellular senescence to neurodegeneration is still unclear. SATB1 is a DNA binding protein associated with Parkinson's disease. We report that SATB1 prevents cellular senescence in post-mitotic dopaminergic neurons. Loss of SATB1 causes activation of a cellular senescence transcriptional program in dopamine neurons both in human stem cell-derived dopaminergic neurons and in mice. We observed phenotypes that are central to cellular senescence in SATB1 knockout dopamine neurons in vitro and in vivo. Moreover, we found that SATB1 directly represses expression of the pro-senescence factor p21 in dopaminergic neurons. Our data implicate senescence of dopamine neurons as a contributing factor in the pathology of Parkinson's disease.Entities:
Keywords: Parkinson’s disease; SATB1; cellular senescence; dopamine; neurodegeneration; neuroinflammation; p21; senolytics; stem cells; transcriptomics
Mesh:
Substances:
Year: 2019 PMID: 31543366 PMCID: PMC7493192 DOI: 10.1016/j.stem.2019.08.013
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633